Redmile Group as of June 30, 2017
Portfolio Holdings for Redmile Group
Redmile Group holds 63 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 8.2 | $135M | 16M | 8.37 | |
| Amicus Therapeutics (FOLD) | 7.4 | $121M | 12M | 10.07 | |
| Clovis Oncology | 5.2 | $86M | 916k | 93.63 | |
| Penumbra (PEN) | 5.0 | $82M | 931k | 87.75 | |
| Puma Biotechnology (PBYI) | 4.6 | $75M | 861k | 87.40 | |
| Juno Therapeutics | 4.0 | $66M | 2.2M | 29.89 | |
| Molina Healthcare (MOH) | 3.5 | $57M | 829k | 69.18 | |
| Inc Resh Hldgs Inc cl a | 3.0 | $49M | 841k | 58.50 | |
| Gw Pharmaceuticals Plc ads | 2.7 | $45M | 445k | 100.25 | |
| Anthem (ELV) | 2.7 | $44M | 232k | 188.13 | |
| Wave Life Sciences (WVE) | 2.5 | $41M | 2.2M | 18.60 | |
| Atara Biotherapeutics (ATRA) | 2.3 | $38M | 2.7M | 14.00 | |
| ImmunoGen | 2.3 | $37M | 5.2M | 7.11 | |
| Oxford Immunotec Global | 2.2 | $36M | 2.2M | 16.82 | |
| Agios Pharmaceuticals (AGIO) | 2.1 | $35M | 681k | 51.45 | |
| Seattle Genetics | 2.1 | $34M | 665k | 51.74 | |
| Regenxbio Inc equity us cm (RGNX) | 2.1 | $34M | 1.7M | 19.75 | |
| Centene Corporation (CNC) | 1.9 | $32M | 398k | 79.88 | |
| Endologix | 1.9 | $31M | 6.4M | 4.86 | |
| Boston Scientific Corporation (BSX) | 1.9 | $30M | 1.1M | 27.72 | |
| Audentes Therapeutics | 1.7 | $28M | 1.5M | 19.13 | |
| Prothena (PRTA) | 1.7 | $28M | 510k | 54.12 | |
| Edwards Lifesciences (EW) | 1.6 | $26M | 218k | 118.24 | |
| Array Biopharma Inc note 3.000% 6/0 | 1.6 | $26M | 19M | 1.35 | |
| Alder Biopharmaceuticals | 1.6 | $26M | 2.2M | 11.45 | |
| Xencor (XNCR) | 1.5 | $25M | 1.2M | 21.11 | |
| Spectranetics Corporation | 1.5 | $24M | 635k | 38.40 | |
| eHealth (EHTH) | 1.4 | $23M | 1.2M | 18.80 | |
| Chimerix (CMRX) | 1.4 | $23M | 4.2M | 5.45 | |
| ICU Medical, Incorporated (ICUI) | 1.4 | $23M | 133k | 172.50 | |
| La Jolla Pharmaceuticl Com Par | 1.3 | $21M | 713k | 29.77 | |
| Irhythm Technologies (IRTC) | 1.2 | $20M | 476k | 42.49 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $19M | 144k | 128.87 | |
| Blueprint Medicines (BPMC) | 1.1 | $19M | 368k | 50.67 | |
| Global Blood Therapeutics In | 1.1 | $17M | 631k | 27.35 | |
| Neuroderm Ltd F | 1.0 | $17M | 555k | 29.90 | |
| NxStage Medical | 1.0 | $17M | 657k | 25.07 | |
| Jounce Therapeutics | 1.0 | $16M | 1.1M | 14.03 | |
| Syros Pharmaceuticals | 0.9 | $16M | 973k | 16.09 | |
| Nanostring Technologies (NSTGQ) | 0.9 | $14M | 867k | 16.54 | |
| Cascadian Therapeutics | 0.8 | $14M | 3.7M | 3.71 | |
| Livanova Plc Ord (LIVN) | 0.8 | $13M | 212k | 61.21 | |
| Model N (MODN) | 0.7 | $11M | 858k | 13.30 | |
| Cytomx Therapeutics (CTMX) | 0.7 | $11M | 698k | 15.50 | |
| Puma Biotechnology | 0.5 | $8.9M | 102k | 87.40 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.5 | $8.3M | 1.6M | 5.20 | |
| Invitae (NVTAQ) | 0.5 | $7.8M | 812k | 9.56 | |
| Glycomimetics (GLYC) | 0.4 | $6.7M | 600k | 11.16 | |
| Medpace Hldgs (MEDP) | 0.4 | $6.5M | 225k | 29.00 | |
| Catalent (CTLT) | 0.3 | $5.1M | 146k | 35.10 | |
| Fate Therapeutics (FATE) | 0.3 | $4.6M | 1.4M | 3.24 | |
| Ovid Therapeutics (OVID) | 0.3 | $4.2M | 449k | 9.44 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $2.6M | 95k | 27.12 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $2.0M | 332k | 6.13 | |
| UnitedHealth (UNH) | 0.0 | $337k | 1.8k | 185.16 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $305k | 6.6k | 45.93 | |
| Nektar Therapeutics (NKTR) | 0.0 | $285k | 15k | 19.55 | |
| Allergan | 0.0 | $292k | 1.2k | 243.33 | |
| Amedisys (AMED) | 0.0 | $211k | 3.4k | 62.87 | |
| Brookdale Senior Living (BKD) | 0.0 | $178k | 12k | 14.70 | |
| Insmed (INSM) | 0.0 | $212k | 12k | 17.12 | |
| Castlight Health | 0.0 | $42k | 10k | 4.11 | |
| Adverum Biotechnologies | 0.0 | $56k | 22k | 2.52 |
